Mortimer Ian
PRESIDENT & CEO at XENE
- Sold, on record
- $24.8M
- Dollars the filings state
- Form 4 sales
- 8
- Latest Mar 13, 2026
- Form 144 notices
- 9
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- XENEXenon Pharmaceuticals Inc.PRESIDENT & CEO
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice XENENoticeDec 1, 2025 2025
Filed to sell 97 shares ($4k)
Mortimer Ian, Officer, Director
10b5-1 plan0x usual sizeFiling
- 2 Form 144 notice XENENoticeDec 5, 2025 +4 days
Filed to sell 14,375 shares ($647k)
Mortimer Ian, Officer, Director
10b5-1 plan0.6x usual sizeFiling
- 3 Form 144 notice XENENoticeDec 8, 2025 +3 days
Filed to sell 10,830 shares ($495k)
Mortimer Ian, Officer, Director
10b5-1 plan0.4x usual sizeFiling
- 4 Form 4 sale XENERoutineDec 8, 2025 same day
Sold 25,205 shares at $45.33 ($1.1M)
Mortimer Ian, PRESIDENT & CEO
10b5-1 planSold 80.8% of holdings ($1.4M position)6,000 shares left1x usual sizeFollows a Form 144Filing
- 5 Form 4 sale XENERoutineJan 2, 2026 +25 days
Sold 40,000 shares at $44.43 ($1.8M)
Mortimer Ian, PRESIDENT & CEO
10b5-1 planSold 87% of holdings ($2M position)6,000 shares left1.6x usual sizeFollows a Form 144Filing
- 6 Form 144 notice XENENoticeJan 2, 2026 same day
Filed to sell 40,000 shares ($1.8M)
Mortimer Ian, Officer, Director
10b5-1 plan1.6x usual sizeFiling
- 7 Form 4 sale XENEUnusualMar 10, 2026 +67 days
Sold 281,269 shares at $60.32 ($17M)
Mortimer Ian, PRESIDENT & CEO
10b5-1 planSold 95% of holdings ($17.9M position)14,731 shares left11.2x usual sizeFiling
- 8 Form 4 sale XENERoutineMar 13, 2026 +3 days
Sold 7,308 shares at $55.23 ($404k)
Mortimer Ian, PRESIDENT & CEO
10b5-1 planSold 26.8% of holdings ($1.5M position)19,923 shares left0.2x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (17)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 13, 2026 | Mar 13, 2026 | XENE | PRESIDENT & CEO | Form 4 sale | 7,308 | $404k | 26.8% | Routine | SEC |
| Mar 10, 2026 | Mar 11, 2026 | XENE | PRESIDENT & CEO | Form 4 sale | 281,269 | $17M | 95.0% | Unusual | SEC |
| Jan 2, 2026 | Jan 2, 2026 | XENE | Officer, Director | Form 144 notice | 40,000 | $1.8M | Notice | SEC | |
| Jan 2, 2026 | Jan 2, 2026 | XENE | PRESIDENT & CEO | Form 4 sale | 40,000 | $1.8M | 87.0% | Routine | SEC |
| Dec 8, 2025 | Dec 9, 2025 | XENE | PRESIDENT & CEO | Form 4 sale | 25,205 | $1.1M | 80.8% | Routine | SEC |
| Dec 8, 2025 | Dec 8, 2025 | XENE | Officer, Director | Form 144 notice | 10,830 | $495k | Notice | SEC | |
| Dec 5, 2025 | Dec 5, 2025 | XENE | Officer, Director | Form 144 notice | 14,375 | $647k | Notice | SEC | |
| Dec 1, 2025 | Dec 1, 2025 | XENE | Officer, Director | Form 144 notice | 97 | $4k | Notice | SEC | |
| Nov 28, 2025 | Dec 3, 2025 | XENE | PRESIDENT & CEO | Form 4 sale | 97 | $4k | 0.3% | Routine | SEC |
| Oct 1, 2025 | Oct 1, 2025 | XENE | Officer, Director | Form 144 notice | 25,000 | $1M | Notice | SEC | |
| Oct 1, 2025 | Oct 1, 2025 | XENE | PRESIDENT, CEO & INTERIM CFO | Form 4 sale | 25,000 | $1M | 44.4% | Routine | SEC |
| Jan 27, 2025 | Jan 27, 2025 | XENE | Officer, Director | Form 144 notice | 16,315 | $661k | Notice | SEC | |
| Jan 27, 2025 | Jan 27, 2025 | XENE | PRESIDENT & CEO | Form 4 sale | 55,000 | $2.2M | 63.7% | Routine | SEC |
| Jan 24, 2025 | Jan 24, 2025 | XENE | Officer, Director | Form 144 notice | 22,468 | $903k | Notice | SEC | |
| Jan 23, 2025 | Jan 23, 2025 | XENE | Officer, Director | Form 144 notice | 16,217 | $650k | Notice | SEC | |
| May 24, 2023 | May 26, 2023 | XENE | PRESIDENT & CEO | Form 4 sale | 31,655 | $1.3M | 50.3% | Unusual | SEC |
| May 24, 2023 | May 24, 2023 | XENE | Director, Officer | Form 144 notice | 31,655 | $1.3M | Notice | SEC |